Page last updated: 2024-10-31

methylphenidate and Abnormality, Heart

methylphenidate has been researched along with Abnormality, Heart in 5 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
"Methylphenidate has been a first line treatment for ADHD, with relatively large numbers of usage."2.66Fetal safety of methylphenidate-A scoping review and meta analysis. ( Barer, Y; Koren, G; Ornoy, A, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Richardson, JL1
George, N1
Greenall, AJ1
Oliver, AM1
Stephens, S1
Hodson, KK1
Koren, G1
Barer, Y1
Ornoy, A1
Huybrechts, KF1
Bröms, G1
Christensen, LB1
Einarsdóttir, K1
Engeland, A1
Furu, K1
Gissler, M1
Hernandez-Diaz, S1
Karlsson, P1
Karlstad, Ø1
Kieler, H1
Lahesmaa-Korpinen, AM1
Mogun, H1
Nørgaard, M1
Reutfors, J1
Sørensen, HT1
Zoega, H1
Bateman, BT1
Batra, AS1
Alexander, ME1
Silka, MJ1
Gothelf, D1
Gruber, R1
Presburger, G1
Dotan, I1
Brand-Gothelf, A1
Burg, M1
Inbar, D1
Steinberg, T1
Frisch, A1
Apter, A1
Weizman, A1

Reviews

2 reviews available for methylphenidate and Abnormality, Heart

ArticleYear
Fetal safety of methylphenidate-A scoping review and meta analysis.
    Reproductive toxicology (Elmsford, N.Y.), 2020, Volume: 93

    Topics: Abnormalities, Drug-Induced; Central Nervous System Stimulants; Female; Fetus; Heart Defects, Congen

2020
Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason.
    Pediatric cardiology, 2012, Volume: 33, Issue:3

    Topics: Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Coro

2012

Trials

1 trial available for methylphenidate and Abnormality, Heart

ArticleYear
Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:10

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

2003

Other Studies

2 other studies available for methylphenidate and Abnormality, Heart

ArticleYear
Cardiac Malformation Risks Following Maternal First Trimester Methylphenidate Use.
    The Journal of clinical psychiatry, 2023, 05-15, Volume: 84, Issue:4

    Topics: Central Nervous System Stimulants; Family; Female; Heart Defects, Congenital; Humans; Methylphenidat

2023
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
    JAMA psychiatry, 2018, 02-01, Volume: 75, Issue:2

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperac

2018